Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition
This paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2016-10-01
|
Series: | Baltic Journal of European Studies |
Subjects: | |
Online Access: | https://doi.org/10.1515/bjes-2016-0012 |
id |
doaj-2e5cb1f3311f402f91c431ee3ea50b52 |
---|---|
record_format |
Article |
spelling |
doaj-2e5cb1f3311f402f91c431ee3ea50b522021-09-05T20:42:30ZengSciendoBaltic Journal of European Studies2228-05962016-10-0162587510.1515/bjes-2016-0012bjes-2016-0012Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after TranspositionRiedel Rafał0Institute for European Studies, Chemnitz University of Technology, Germany Opole University ul. Katowicka 89, Opole 45-061, PolandThis paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal scope and subject matter of the new legislation, conclusions of the evaluative reports monitoring its implementation and performance as well as the public opinion polls revealing the EU citizens’ perception of its details. These three components combined together deliver a picture of the state of play about the pan-European cross-border patients’ mobility. The bottomline conclusions negatively verify the supposition present in some earlier literature on patients’ cross-border mobility that the directive has a transformative potential leading towards the creation of truly competitive pan-European medical market. After two years of its operation, there is still no increased patients’ mobility across EU internal borders observed. As regards the speculations for the future, there are only some weak symptoms identified and they may result in intensified cross-border mobility for healthcare.https://doi.org/10.1515/bjes-2016-0012cross-border healthcaredirectivepatients’ mobility |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Riedel Rafał |
spellingShingle |
Riedel Rafał Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition Baltic Journal of European Studies cross-border healthcare directive patients’ mobility |
author_facet |
Riedel Rafał |
author_sort |
Riedel Rafał |
title |
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition |
title_short |
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition |
title_full |
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition |
title_fullStr |
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition |
title_full_unstemmed |
Patient’s Cross-border Mobility Directive: Application, Performance and Perceptions Two Years after Transposition |
title_sort |
patient’s cross-border mobility directive: application, performance and perceptions two years after transposition |
publisher |
Sciendo |
series |
Baltic Journal of European Studies |
issn |
2228-0596 |
publishDate |
2016-10-01 |
description |
This paper seeks to analyse the directive on the application of patients’ rights in cross-border healthcare. Two years after the transposition, it is time for first evaluations of its application, performance and perception. The analysis consists of three major elements: reconstruction of the legal scope and subject matter of the new legislation, conclusions of the evaluative reports monitoring its implementation and performance as well as the public opinion polls revealing the EU citizens’ perception of its details. These three components combined together deliver a picture of the state of play about the pan-European cross-border patients’ mobility. The bottomline conclusions negatively verify the supposition present in some earlier literature on patients’ cross-border mobility that the directive has a transformative potential leading towards the creation of truly competitive pan-European medical market. After two years of its operation, there is still no increased patients’ mobility across EU internal borders observed. As regards the speculations for the future, there are only some weak symptoms identified and they may result in intensified cross-border mobility for healthcare. |
topic |
cross-border healthcare directive patients’ mobility |
url |
https://doi.org/10.1515/bjes-2016-0012 |
work_keys_str_mv |
AT riedelrafał patientscrossbordermobilitydirectiveapplicationperformanceandperceptionstwoyearsaftertransposition |
_version_ |
1717785582366621696 |